| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 08/26/2008 | US7417048 Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets |
| 08/26/2008 | CA2208981C Novel trienoic retinoid compounds and methods |
| 08/21/2008 | WO2008099727A1 Α-substituted acrylate derivative and method for producing the same |
| 08/21/2008 | US20080200724 Process and Compound |
| 08/21/2008 | US20080200525 Pesticidally active ketone and oxime derivatives |
| 08/20/2008 | EP1957445A2 Fluorinated gemini surfactants |
| 08/20/2008 | EP1957443A2 Method for producing sulfonamides |
| 08/20/2008 | EP1956907A2 Cyanobenzene compounds for combating animal pests |
| 08/20/2008 | EP1249233B1 Npyy5 antagonists |
| 08/20/2008 | CN101245058A Inhibitors of aspartyl protease |
| 08/20/2008 | CN101245040A Process for producing 4-ethynyl benzene sulfonamide (I) |
| 08/20/2008 | CN101245039A Process for producing cis-4-(2-bromine vinyl)benzene sulfonamide(I) |
| 08/19/2008 | US7414152 N-substituted p-menthane carboxamides |
| 08/19/2008 | US7414144 Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines |
| 08/19/2008 | US7414076 Methods and compositions for treating amyloid-related diseases |
| 08/19/2008 | US7414011 Pyridine, pyrimidine or triazine derivatives; selectivity; safe for agricultural plants including transgenics; synthesis |
| 08/19/2008 | US7413843 Sulfonamide compound, polymer compound, resist material and pattern formation method |
| 08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 08/14/2008 | WO2008098244A1 Novel antagonists of the glucagon receptor |
| 08/14/2008 | US20080194691 Apoptosis Promoters |
| 08/14/2008 | CA2678265A1 Novel antagonists of the glucagon receptor |
| 08/13/2008 | EP1824837B1 Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds |
| 08/13/2008 | EP1548750B1 Nonaqueous electrolyte, electrical double layer capacitors, and nonaqueous electrolyte secondary cells |
| 08/13/2008 | CN100409844C Noval compound, its synthetizing process and therapeutic use |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411002 spermine derivatives; prevention of the binding of endotoxins with their biological receptors; Toll-like receptors inhibitor; antiseptic, antiinflammatory agent; sepsis, eye disease and uveitis, Behcet's disease or atherosclerosis, chronic lung disease and asthma |
| 08/07/2008 | WO2008093767A1 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
| 08/07/2008 | WO2008014313A3 A process for forming perfluorinated-alkyl sulfonamide substituted norbornene-type monomers |
| 08/07/2008 | US20080188659 Method for Preparing Halogenated Amines |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/07/2008 | US20080187998 For use as endosomolytic reagents for transfection with polymeric or lipid-based vectors; in vitro transfection; liposomes; plasmids |
| 08/07/2008 | CA2677061A1 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
| 08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
| 08/06/2008 | EP1951702A2 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
| 08/06/2008 | EP1951663A2 (r)-arylkylamino derivatives and pharmaceutical compositions containing them |
| 08/06/2008 | EP1476149B1 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
| 08/06/2008 | EP1311475B1 Aminocyclohexane derivatives |
| 08/06/2008 | CN100408556C Modulation of anxiety through blockade of anandamide hydrolysis |
| 08/06/2008 | CN100408539C Vitamin d receptor modulators |
| 08/05/2008 | US7408008 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 08/05/2008 | US7407988 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 08/05/2008 | CA2337098C Anthranilic acid derivatives |
| 07/31/2008 | WO2008040947A3 Soluble diazoalkane precursors |
| 07/31/2008 | US20080182906 Therapy for diabetic retinopathy |
| 07/31/2008 | US20080182881 TNF-alpha production inhibitors |
| 07/30/2008 | EP1948593A2 Process for the preparation of tamsulosin and related compounds |
| 07/30/2008 | CN101233101A Stable aqueous dispersions of colour developer |
| 07/30/2008 | CN100407493C 非水电解质和非水电解质二次电池 The non-aqueous electrolyte and a nonaqueous electrolyte secondary battery |
| 07/30/2008 | CN100406449C CDC25 phosphatase inhibitors |
| 07/30/2008 | CN100406007C Asthma and allergic inflammation modulators |
| 07/29/2008 | US7405229 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2214323C Compounds and compositions for delivering active agents |
| 07/24/2008 | WO2008088727A2 Endothelin receptor antagonists |
| 07/24/2008 | US20080177107 isolating a substance having antiandrogenic activity from the bark of the African plum tree P. africana, and synthesising structural variants of these substances; even able to inhibit the growth of prostate cancer cells that do not respond to treatment with hydroxyflutamide |
| 07/24/2008 | US20080176939 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 07/24/2008 | US20080176916 A-amino-n-hydroxy-acetamide derivatives |
| 07/24/2008 | US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus |
| 07/23/2008 | EP1675823B1 Phenethanolamine derivatives for the treatment of respiratory diseases |
| 07/23/2008 | EP1246797B1 Cyclopentyl sulfonamide derivatives |
| 07/23/2008 | CN101228121A Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5HT6 receptor |
| 07/23/2008 | CN101228120A HIV reverse transcriptase inhibitors |
| 07/23/2008 | CN101228119A Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5HT6 receptor |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402598 Arylethanolamine β2-adrenoreceptor agonist compounds |
| 07/17/2008 | WO2008083729A1 Radiolabelling via fluorination of aziridines |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | CA2674408A1 Radiolabelling via fluorination of aziridines |
| 07/16/2008 | EP1944300A2 Prodrugs of aspartyl protease inhibitors |
| 07/16/2008 | EP1944288A1 Radiolabelling via fluorination of aziridines |
| 07/16/2008 | EP1631995B1 Manufacture of a polymer device |
| 07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
| 07/16/2008 | EP1244610B1 Improved preparation of 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines |
| 07/16/2008 | CN101223132A Process for the preparation of sulfonamide derivatives |
| 07/16/2008 | CN100402495C Aminoalkylamide substituted cyclohexyl derivatives |
| 07/15/2008 | US7399775 β-amyloid protein production/secretion inhibitor |
| 07/10/2008 | US20080167351 Compounds Which Potentiate Glutamate Receptor and Uses Thereof in Medicine |
| 07/10/2008 | US20080167331 Lowering intraocular pressure; glaucoma |
| 07/09/2008 | EP1942103A1 Method for producing optically active benzylamine derivative |
| 07/09/2008 | EP1940785A2 Acyclic 1,4-diamines and uses thereof |
| 07/09/2008 | EP1940784A2 Halo active aromatic sulfonamide organic compounds and odor control uses therefor |
| 07/09/2008 | EP1940782A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 07/09/2008 | EP1940781A1 Phenyl-acetamide nnrt inhibitors |
| 07/09/2008 | EP1220846B1 Method for producing substituted phenylsulfonyl carbamides from sulfohalogenides |
| 07/09/2008 | CN100400512C Benzoic acid derivatives as modulators of PPAR alpha and gamma |
| 07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
| 07/08/2008 | US7396958 Sulphonamide derivatives, their preparation and their therapeutic application |
| 07/08/2008 | US7396859 Perturbed membrane-binding compounds |
| 07/08/2008 | US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases |
| 07/03/2008 | WO2007147222A3 Novel ionic liquids |
| 07/03/2008 | US20080161401 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 07/03/2008 | US20080161345 Aryl Sulfonamides |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | CA2664118A1 Protease inhibitors |
| 07/02/2008 | EP1937632A1 Novel compounds |
| 07/02/2008 | EP1937631A2 Hiv-1 protease inhibitors |
| 07/02/2008 | EP1937242A2 Methods and compositions for the treatment of neuropsychiatric and addictive disorders |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | CN101209974A Hydroxamic acids derivatives and use thereof |
| 07/01/2008 | US7393873 Arylsulfonamide derivatives |